The biotech’s G12D-selective RAS blocker has demonstrated its first and second-line combinatory potential in pancreatic ...

A real-world analysis investigates the impact of concurrent GLP-1 RA use on long-term survival and the safety profile of patients with solid and hematologic malignancies receiving immune checkpoint ...

A Cavendish Maxwell study found that off-plan sales continue to dominate the market, accounting for 85 per cent of residential transactions and generating Dhs11.2bn in sales during 2025 ...

Revolution Medicines launches a phase III study of zoldonrasib plus chemotherapy in first-line metastatic PDAC harboring RAS G12D mutations.

Off-plan sales outpace ready purchases as transaction volumes hit AED12.3 billion; Ras Al Khaimah, UAE – The Emirate of Ras ...

About 170 homes were delivered in Q1 2026, another 1,700 are set to come to the market this year, followed by 23,900 by the ...

Strategically positioned with direct access to University City and Sharjah Airport Free Zone, Vida Aljada is also within easy reach of Dubai International Airport and Sharjah Corniche ...

A new study reveals a potential link between a common blood pressure medication and an increased risk of kidney damage, ...

Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.

According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist ...

Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and ...